L-745,870 |
0.43–0.51 |
In vivo administration in rodents for functional, behavioural and drug-dependence studies [177–179]; development of PET radioligands [180]; in D4 receptor-overexpressing cell systems [52, 181]; tests for antipsychotic activity [120, 182] |
L-741,742 |
3.5 |
In vivo administration to mice for anxiety testing [183] |
ABT 724 |
~45–65 |
In vivo administration to rats to test potential treatment of erectile dysfunction [184, 185] |
WAY 100635 |
16.4 |
D4 receptor agonist and 5HT1A antagonist; produces discriminative stimulus effects in rats [186, 187] |
PD 168077 |
8.7 |
Selective D4 agonist, proerectile effect in rats [188]; tested in mice for memory consolidation studies [189] |
PNU 96415E |
3 |
Tested for antipsychotic potential [190] |
Ro 10-5824 |
5.2 |
Selective D4 agonist, increases novel exploration in mice [191] |
NGD 94-1 |
3 |
In vivo administration to monkey for cognitive and memory tests [192]; in vitro autoradiography studies [193, 194] |
NRA 0160 |
0.5 |
Tested for antipsychotic activity in animal models [195, 196] |
CI 1030 |
4.3 |
Tested for antipsychotic activity in animal models [195, 196] |
A-412997 |
7.9 |
D4 receptor agonist; improves cognitive performance and stimulates motor activity in rats [197] |